Genome wide DNA methylation analysis identifies novel molecular subgroups and predicts survival in neuroblastoma
Open Access
- 29 September 2022
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 127 (11) , 2006-2015
Abstract
Background: Neuroblastoma is the most common malignancy in infancy, accounting for 15% of childhood cancer deaths. Outcome for the high-risk disease remains poor. DNA-methylation patterns are significantly altered in all cancer types and can be utilised for disease stratification.Methods: Genome-wide DNA methylation (n = 223), gene expression (n = 130), genetic/clinical data (n = 213), whole-exome sequencing (n = 130) was derived from the TARGET study. Methylation data were derived from HumanMethylation450 BeadChip arrays. t-SNE was used for the segregation of molecular subgroups. A separate validation cohort of 105 cases was studied.Results: Five distinct neuroblastoma molecular subgroups were identified, based on genome-wide DNA-methylation patterns, with unique features in each, including three subgroups associated with known prognostic features and two novel subgroups. As expected, Cluster-4 (infant diagnosis) had significantly better 5-year progression-free survival (PFS) than the four other clusters. However, in addition, the molecular subgrouping identified multiple patient subsets with highly increased risk, most notably infant patients that do not map to Cluster-4 (PFS 50% vs 80% for Cluster-4 infants,P = 0.005), and allowed identification of subgroup-specific methylation differences that may reflect important biological differences within neuroblastoma.Conclusions: Methylation-based clustering of neuroblastoma reveals novel molecular subgroups, with distinct molecular/clinical characteristics and identifies a subgroup of higher-risk infant patients.Keywords
Funding Information
- National Institute of Health
- National Institute of Health and Funding by the EU
- Kidscan Children's Cancer Research
This publication has 37 references indexed in Scilit:
- Low-level processing of Illumina Infinium DNA Methylation BeadArraysNucleic Acids Research, 2013
- Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarrayEpigenetics, 2013
- The genetic landscape of high-risk neuroblastomaNature Genetics, 2013
- DNA Methylation and Its Basic FunctionNeuropsychopharmacology, 2012
- Molecular subtypes of breast cancer are associated with characteristic DNA methylation patternsBreast Cancer Research, 2010
- Recent Advances in NeuroblastomaNew England Journal of Medicine, 2010
- The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force ReportJournal of Clinical Oncology, 2009
- Allelic deletion at 11q23 is common in MYCN single copy neuroblastomasOncogene, 1999
- Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinomaProceedings of the National Academy of Sciences, 1998
- Amplification of N- myc in Untreated Human Neuroblastomas Correlates with Advanced Disease StageScience, 1984